𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A model of natural selection that exhibits a dynamic phase transition

✍ Scribed by Ed Weinberger

Publisher
Springer
Year
1987
Tongue
English
Weight
784 KB
Volume
49
Category
Article
ISSN
0022-4715

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A simple lattice model that exhibits a p
A simple lattice model that exhibits a protein-like cooperative all-or-none folding transition
✍ Andrzej Kolinski; Dominik Gront; Piotr Pokarowski; Jeffrey Skolnick πŸ“‚ Article πŸ“… 2003 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 180 KB

## Abstract In a recent paper (D. Gront et al., __Journal of Chemical Physics__, Vol. 115, pp. 1569, 2001) we applied a simple combination of the Replica Exchange Monte Carlo and the Histogram methods in the computational studies of a simplified protein lattice model containing hydrophobic and pola

Model A Dynamics and the Deconfining Pha
Model A Dynamics and the Deconfining Phase Transition
✍ Bernd A. Berg; Hildegard Meyer-Ortmanns; Alexander Velytsky πŸ“‚ Article πŸ“… 2005 πŸ› Elsevier Science 🌐 English βš– 137 KB

We consider model A dynamics for a quench from the disordered (confined) to the ordered (deconfined) QCD phase. The linear theory of spinodal decompositions is compared with data from an effective spin model. The critical mode of the linear approximation is determined. Further, the quench leads to c

Coformer selection in pharmaceutical coc
Coformer selection in pharmaceutical cocrystal development: A case study of a meloxicam aspirin cocrystal that exhibits enhanced solubility and pharmacokinetics
✍ Miranda L. Cheney; David R. Weyna; Ning Shan; Mazen Hanna; Lukasz Wojtas; Michae πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 475 KB

Meloxicam is a nonsteroidal anti-inflammatory drug with low aqueous solubility and high permeability. Because of its low solubility under acidic conditions (e.g., pH 1-5), it can take more than 2 h for meloxicam to reach its therapeutic concentration in humans. Although the slow onset of meloxicam d